Bacteria that light up to reveal their activity

Excellent integration of upstream controls (Phase 1 in silico) to anticipate specificity and retention problems before costly experiments, thereby reducing the risk of late-stage failure.

The hypothesis proposes a clear, testable quantitative framework rooted in Michaelis-Menten kinetics, which constitutes a rigorous, mechanistic approach to linking fluorescence intensity to specific enzymatic activity, a step beyond simple binary detection.

The approach of intracellular retention by logP and negative charge is elegant and rests on well-understood physical chemistry, which constitutes a solid starting point.

A niche but identifiable market: biotechnology companies developing therapies targeting the microbiome (e.g., Vedanta Biosciences, Seres Therapeutics) and CROs specialising in functional metagenomics (e.g., Diversigen, CosmosID) would pay for a tool that validates the in situ enzymatic activity of specific strains within synthetic communities, particularly for the screening of drug candidates that modulate the microbiota.

A clear and testable mechanistic hypothesis (Michaelis-Menten, intracellular retention by logP/charge) is presented, which constitutes a major asset for funding reviewers requiring quantitative rigour.